Unituxin and Brain scan abnormal - a phase IV clinical study of FDA data

Summary:

We study 1,259 people who take Unituxin (dinutuximab) or have Brain scan abnormal. No report of Brain scan abnormal is found in people who take Unituxin.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Unituxin?

Unituxin has active ingredients of dinutuximab. eHealthMe is studying from 489 Unituxin users. Check the latest studies of Unituxin.

What is Brain Scan Abnormal?

Brain scan abnormal is found to be associated with 190 drugs and 290 conditions by eHealthMe. Check the latest studies of Brain scan abnormal.

On Jun, 18, 2026

No report is found.

Do you take Unituxin and have Brain scan abnormal?

- Check whether Brain scan abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Unituxin:

Unituxin (489 reports)

Browse all side effects of Unituxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Brain scan abnormal:

Brain scan abnormal

Browse all the conditions that are associated with Brain scan abnormal:

Brain scan abnormal

How the study uses the data?

The study uses data from the FDA. It is based on dinutuximab (the active ingredients of Unituxin) and Unituxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.